LCM
PFE icon

Legato Capital Management’s Pfizer PFE Stock Holding History

Legato Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
145,221
+439
+0.3% +$11.5K 0.29% 98
2026
Q1 		$4.07M Buy
144,782
+36,058
+33% +$960K 0.37% 53
2025
Q4 		$2.71M Buy
+108,724
New +$2.74M 0.23% 105

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Legato Capital Management's PFE Position: Q2 2026 in Review

Legato Capital Management increased its Pfizer (PFE) stake by 0.3% in Q2 2026, buying an estimated $11.5K and bringing the position to 145,221 shares worth $3.5M. The position accounts for 0.29% of the portfolio, ranked #98.

Legato Capital Management first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.07M in Q1 2026. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Legato Capital Management held 145,221 shares of Pfizer worth $3.5M as of Q2 2026.
  • Legato Capital Management bought 439 Pfizer shares in Q2 2026, an estimated $11.5K.
  • Pfizer made up 0.29% of Legato Capital Management's portfolio in Q2 2026, its #98 holding.
  • Legato Capital Management first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Legato Capital Management's Pfizer position peaked at $4.07M in Q1 2026.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.